Eumedica is thrilled to have reached the oustanding milestone of having more than 2000 followers on LinkedIn. We want to warmly thank everyone who is engaging with our page and are looking forward to sharing more exciting news with you.
You’re not a follower yet? Here are a few reasons why you should join our community on LinkedIn:
Be the first to hear about our new services and business opportunities;
Find out about all congresses and other events we attend;
Check out our job opportunities and get the chance to join our growing company.
Hopefully, we’ll count you soon as one of our followers on LinkedIn.
In order to meet constant growing demand, we are proud to announce the extension of our warehouse floor space from 7000sqm to 10000sqm. This exciting development is set to provide our customers with more GDP storage spaces and GMP rooms (labelling and packaging) for cold and ambient pharmaceutical products.
This new 3000sqm warehouse is designed to expand our activities through the following areas:
GDP storage for pharmaceutical products at 15-25°C; 2-8°C; -20°C and -40°C
GMP rooms for labelling and packaging at 15-25°C; 2-8°C; -20°C
“This new infrastructure is the logical continuation of former extensions and falls within our mission to ensure medical care continuity. Everyone at Eumedica is very excited by this expansion and recognise it will extend customers’ satisfaction with the same standards of services, flexibility and know-how that we have been providing for 35 years.” Virginie De Coster, Managing Director.
We are committed to our ethos of ensuring medical care continuity and bringing vital medicines to care-givers and patients throughout the world. To this end, we have recently been approved as an AEO (Authorised Economic Operator).
What is AEO status?
The AEO is granted to companies who are involved in customs operations and international trade, and meet a range of strict criteria related to supply chain security. It shows that our business’ role in the global supply chain is secure and reliable. In other words, it seeks to create a frictionless relationship between us and customs authorities around the world, based on mutual confidence and integrity.
What are the advantages?
In the first instance, we have been awarded the Authorised Economic Operator Customs Simplification (AEOC) status. This certificate, not only recognises our reliability and stringent processes, but also allows us to benefit from:
Easier admittance to customs simplifications
Priority treatment if selected for control
Possibility to request a specific place for customs controls
Fewer physical and document-based controls related to other customs legislation
The AEOC status is vital for our company to allow us to meet the global demands of our customers; expediting procedures to get our products to where they are needed, to help patients around the world.
Should you need more information about our services, feel free to complete the contact form.
With the Brexit transition period drawing to an end on 31st December 2020, we shall enter the new year with many rules changing on the import of goods from the EU into the UK. We have been working tirelessly to adapt to this new environment and ever striving to bridge this gap between Europe and the UK.
We are very proud to announce the launch of a new Eumedica entity: Eumedica Pharma Ltd. This new entity will enable us to overcome many of the challenges Brexit has presented all companies who rely on a European partnership, like us.
The transition period
Back in January 2020 saw the beginning of the transition period to the end of this year. We formed a new alliance with a UK distributor to store and ship medicines throughout the UK hospital network to maintain our commitment to vital medical care continuity. This guaranteed no disruption to the supply of our medicines for our customers and patients throughout this uncertain and trying period.
Our customers and the new entity
Our main priority is to limit the impact on our customers as much as possible. From the 1st January 2021 the only aspect that will change is our contact details; the team who have always managed your orders and the distributors who have delivered our medicines to you, will remain the same. Furthermore, our sales and promotion team, led by Véronique Van Ranst, Head of the UK Markets, continue to support you and will be on hand to deal with any queries you may have.
New contact details
From 1st January 2021 please use the following contact details if you contact us from the UK:
In the current climate of the Coronavirus pandemic, Eumedica is dedicated to carry out its mission: “Ensuring Medical Care Continuity”. This is only possible through the continued hard-work and dedication of our colleagues. This is why the health and safety of our colleagues is of the utmost importance, now more than ever. Where feasible, we have implemented homeworking. Some of what we do needs to be done on site; we therefore constantly monitor the situation and are taking appropriate measures to ensure the safety of our people.
What Eumedica is doing in-house
Providing a safe working environment for all of our colleagues is our top-priority. To achieve this, we have reduced the number of people on site to the absolute minimum required and have implemented home-based working for all other colleagues. We are raising awareness internally around increased hygiene measures, strengthening our disinfection plan, cancelling all non-essential business travel, and keeping a minimum of 1.5m distance. With regards to our clients, we maintain contact using video-conferencing, telephone and email. We are always available to answer our clients queries!
In a matter of just a few days, we have all embraced the new digital tools to keep our teams working for you!
Medicines distribution, a vital service
As a key distributor of medicines, we are a vital service for the population across many countries. Consequently, it is crucial to continue our work so patients can receive their treatment on time. All our teams work tirelessly to maintain the supply of medicines for these patients. Therefore, we guarantee to remain operational and continue all our GDP and GMP activities and to manage all orders and requests. Meanwhile, we will be dynamic to any changes made by the authorities on a local, continental or worldwide scale, and act accordingly.
In these challenging times, we would like to thank all of our colleagues who are working hard to deliver vital medicines to patients. While we make sure the conditions are as safe as possible, we are proud to see such flexibility and cohesion to fulfil our mission: “Ensuring Medical Care Continuity”!
two years, Eumedica has been a certified and licensed PAXXO partner for distributing the Pactosafe
4.0 system in Belgium, Luxembourg and northern France (Ardennes,
Meurthe-et-Moselle, Meuse and Nord).
This equipment is crucial to health care staff as it provides a safer working environment, preventing the exposure and consequences related to cytotoxic drug contamination and inhalation. At the same time, it allows health care staff to carry out their duties in a hygienic working environment.
Pactosafe 4.0 was developed by the world leaders in the field of waste management to prevent health care personnel from the exposure of hazardous drugs as well as infection control and to avoid odour. It has been developed to quickly store and tightly pack contaminated waste without any extra handling and therefore preventing contamination. Pactosafe is 100% airtight and the bag cassette is permeation tested for cytotoxic drugs which prevents health care staff from hazardous exposure.
worldwide within health care facilities, the new Pactosafe 4.0 offers easier use and maintenance. Furthermore, it is
also more eco-friendly as it uses 40% less materials.
For more information about this unique equipment, or to arrange a free demo at your premises, please feel free to contact us.
Remember back in February the Falsified Medicines Directive (FMD) came into force in the European Union. Eumedica is thrilled to announce that a new serialization printing line has been setup to enlarge the service range we propose to the pharmaceutical industry.
What does the FMD imply?
Back to basics first. This directive imposes amongst others a unique serial number printed on the box on all products prescribed in the European zone.
he goal: limit to the maximum the access to counterfeit products on the market as this represents a major risk for the patients’ health.
On every packaging, a data matrix and other
required data must be printed:
product code (code GTIN)
unique and random serial number
What we offer
To help you face this new challenge in our industry, we have invested in a new printing line specifically set up to comply with FMD requirements. Thanks to this equipment our team of experts can now provide you with a flexible solution to meet your needs and expectations.
In addition, we can also:
manage the status check of the serial numbers
decommission and/or recommission unique serial numbers
Are you looking for a new partner for printing your packaging? Do you need further information? Feel free to contact us right now!
April we participated as exhibitor to the 29th ECCMID (European
Congress of Clinical Microbiology & Infectious Diseases) in Amsterdam,
like to thank everyone who came and visited us during the congress. It was a
pleasure to meet you and discuss the latest
developments in infectious diseases, infection control and clinical
that you enjoyed the congress and received all the answers you were looking
A few months have passed now and you still have remaining questions? You couldn’t come to the ECCMID? In any case, do not hesitate to contact us.
decision on Brexit has still to be made. The new extension to Article 50, negotiated
between Theresa May and the European leaders, means that the deferment of
Brexit could continue to 31st October 2019. Whilst Theresa May
agreed this date, she still hopes to convince the UK parliament to approve the
Withdrawal Agreement and on or before May 22nd.
customers’ specific needs are our top priority. The Eumedica team has worked
hard to make any Brexit outcome as smooth as possible, with no disruption to
the supply of our medicines to UK hospitals.
medicines to hospitals in UK and will continue: Brexit or not
We are pleased
to be able to announce that Eumedica has partnered with a local supplier in the
United Kingdom to store and ship medicines to UK Hospitals. Please note that Eumedica will continue to
take orders and issue the invoices from Manage in Belgium, while the UK market medicines
will be delivered directly from our UK storage facility.
How will this benefit to our
This new storage facility will ensure that we are able to respond
quickly, and in a more flexible way, to any of our customers’ requests in
United Kingdom. They will benefit from:
• a faster delivery: your goods will be delivered after 24h instead of 48h
• no border control delays
• serialized products will be directly available in UK
• a smooth Brexit with business continuity – whatever the final outcome
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.